{"id":"NCT01086384","sponsor":"GlaxoSmithKline","briefTitle":"Asthma Exacerbation Study","officialTitle":"A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02-22","primaryCompletion":"2011-09-01","completion":"2011-09-15","firstPosted":"2010-03-15","resultsPosted":"2013-09-11","lastUpdate":"2018-01-24"},"enrollment":2020,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Fluticasone Furoate/GW642444","otherNames":[]},{"type":"DRUG","name":"Fluticasone furoate","otherNames":[]}],"arms":[{"label":"Fluticasone furoate/GW642444","type":"EXPERIMENTAL"},{"label":"fluticasone furoate","type":"EXPERIMENTAL"}],"summary":"This study will establish the safety as well as demonstrate benefit of the addition of a LABA to an ICS by utilizing an endpoint (time to first severe asthma exacerbation) that informs on both safety and efficacy.","primaryOutcome":{"measure":"Number of Participants With 1 or More Severe Asthma Exacerbations","timeFrame":"Baseline to Follow-up (up to 76 weeks of treatment)","effectByArm":[{"arm":"FF 100 µg","deltaMin":186,"sd":null},{"arm":"FF/VI 100/25 µg","deltaMin":154,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.036"},{"comp":"OG000 vs OG001","p":"0.036"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":183,"countries":["United States","Argentina","Australia","Germany","Japan","Mexico","Philippines","Poland","Romania","Russia","Ukraine"]},"refs":{"pmids":["27881132","26704701","24253831"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":1010},"commonTop":["Headache","Nasopharyngitis","Upper respiratory tract infection","Bronchitis","Cough"]}}